Sign Up Today and Learn More About Onc.AI Stock
Invest in or calculate the value of your shares in Onc.AI or other pre-IPO companies through EquityZen's platform.
Onc.AI Stock
Onc.AI is a software that specializes in clinical oncology, genomics, proteomics, and radiomics.
About Onc.AI Stock
Founded
2020
Headquarters
San Carlos, CA, US
Industries
Software, Data and Analytics, Artificial Intelligence
Onc.AI Press Mentions
Stay in the know about the latest news on Onc.AI
Onc.AI to Present Collaboration Results Demonstrating Immunotherapy Response Prediction Using a Radiomic Signature in Late-Stage Lung Cancer
businesswire • Aug 03, 2024
Onc.AI Raises $25 Million Series A Financing Co-Led by MassMutual and Action Potential Venture Capital
businesswire • Jan 31, 2023
MassMutual backs Onc.AI
coverager • Jan 12, 2023
Onc.AI Management
Leadership team at Onc.AI
Co-Founder and CEO
Akshay Nanduri
Board Advisor / Investor
Thomas Hawes
Join now and verify your accreditation status to gain access to:
- Onc.AI current valuation
- Onc.AI stock price
- Available deals in Onc.AI and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
How to invest in Onc.AI stock?
Accredited investors can buy pre-IPO stock in companies like Onc.AI through EquityZen funds. These investments are made available by existing Onc.AI shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Onc.AI stock?
Shareholders can sell their Onc.AI stock through EquityZen's private company marketplace. EquityZen's network includes over 310K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 42K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
